AstraZeneca says COVID-19 booster effective against omicron in study

Antibody levels against omicron following a third dose of its vaccine were broadly similar to antibody levels against the Delta variant achieved after two doses, said the pharmaceutical group.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.